Publisher： Adis International
ISSN： 1174-5886
Source： Drugs in R&D, Vol.4, Iss.3, 2003-01, pp. : 161-166
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. :
Depot medroxyprogesterone increases risk of cardiovascular disease?
Inpharma, Vol. 1, Iss. 1355, 2002-01 ,pp. :
Clinical Pharmacokinetics of Depot Leuprorelin
By Periti P. Mazzei T. Mini E.
Clinical Pharmacokinetics, Vol. 41, Iss. 7, 2002-01 ,pp. :
Guidelines for depot antipsychotic treatment in schizophrenia
By Kane J.M. Aguglia E. Altamura A.C. Gutierrez J.L.A. Brunello N. Fleischhacker W.W. Gaebel W. Gerlach J. Guelfi J.-D. Kissling W. Lapierre Y.D. Lindstrom E. Mendlewicz J. Racagni G. Carulla L.S. Schooler N.R.
European Neuropsychopharmacology, Vol. 8, Iss. 1, 1998-02 ,pp. :